Clinical Trial

"Salivary Melatonin and Cortisol Levels in Individuals with Bruxism"

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 4, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The effects of the hormones melatonin and cortisol, which play a highly effective role in regulating the sleep-wake cycle, on teeth grinding will be scientifically evaluated. Based on the research results, more effective methods for treating patients suffering from bruxism may be identified.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-01.
Trial Details
NCT Number NCT06623643
Lead Sponsor Yuzuncu Yil University
Conditions Bruxism
Enrollment 100 participants
Start Date 2024-10-30
Primary Completion 2024-12-30 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-10-04